Life sciences investment firm that partners with teams pursuing breakthrough medicines that improve the lives of patients. The firm includes a collaborative, global team of seasoned biotech investors, company-builders, operators, and industry analysts, that aim to serve the companies into which they invest by bringing both capital and substantive biotech expertise.
The firm had designed, built, financed, and supported both novel platforms and approved medicines. They are guided by the desire to enable high-value medicines, and so they work across therapeutic areas in a modality-agnostic manner, partnering with companies ranging from discovery platforms to those in clinical development.
